Paragon 28, Inc. (FNA)

Market Cap	1.09B
Revenue (ttm)	245.00M
Net Income (ttm)	-56.15M
Shares Out	83.86M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,153,651
Open	13.07
Previous Close	13.05
Day's Range	13.01 - 13.07
52-Week Range	4.65 - 13.35
Beta	1.55
Analysts	Buy
Price Target	15.20 (+16.74%)
Earnings Date	Mar 3, 2025

About FNA

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunio...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 15, 2021
• Employees: 574
• Stock Exchange: NYSE
• Ticker Symbol: FNA
• Website: https://paragon28.com

Financial Performance

In 2023, Paragon 28's revenue was $216.39 million, an increase of 19.30% compared to the previous year's $181.38 million. Losses were -$47.84 million, -28.94% less than in 2022.

Analyst Forecast

According to 7 analysts, the average rating for FNA stock is "Buy." The 12-month stock price forecast is $15.2, which is an increase of 16.74% from the latest price.

Price Target

$15.2

(16.74% upside)

Analyst Consensus: Buy